Tivumecirnon
Tivumecirnon (FLX475) is an orally bioavailable, selective CCR4 antagonist that blocks regulatory T cell (Treg) migration into tumors. This mechanism has demonstrated antitumor activity in preclinical models, supporting its research use in oncology for modulating the tumor microenvironment.
Product Specifications
CAS Number
2174938-78-2
Product Name Alternative
FLX 475, FLX475, FLX-475, Tivumecirnon
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
99.88% (May vary between batches)
Solubility
10% DMSO+90% Corn Oil:3.3 mg/mL (6.07 mM) ; DMSO:80 mg/mL (147.22 mM)
Smiles
[C@H] (C) (N1C=2C (C (C (F) (F) F) =N1) =NC=C (N2) N3CC (C3) [C@@H]4CN (CCO) CCC4) C5=C (Cl) C=C (Cl) C=C5
Molecular Formula
C24H27Cl2F3N6O
Molecular Weight
543.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742831-100 1x 100 µL
DOG-1 / TMEM16A (Gastrointestinal Stromal Tumor Marker) (DG1/2831R), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472307-100 1x 100 µL
Moesin (rMSN/492), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC426270 20 µg
C1orf38 (THEMIS2) (NM_001105556) Human Over-expression Lysate
Sign In for Pricing
View Details 